We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 420.00
Bid: 413.00
Ask: 424.00
Change: 30.00 (7.69%)
Spread: 11.00 (2.663%)
Open: 410.00
High: 420.00
Low: 406.00
Prev. Close: 390.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

8 Aug 2017 07:00

RNS Number : 3393N
Zotefoams PLC
08 August 2017
Ā 

Tuesday 8 August 2017

Ā 

Zotefoams plc

("Zotefoams", or "the Group" or "the Company")

Ā 

Directorate changes

Ā 

Zotefoams plc, a world leader in cellular materials technology, is pleased to announce the appointment of Doug Robertson as a Non-Executive Director and Chair of the Audit Committee, with effect from 8 August 2017. Doug is also appointed as a member of the Nominations and Remuneration Committees, alongside the other Non-Executive Directors.

Ā 

Doug was Group Finance Director of SIG plc until his retirement in January this year. Prior to joining SIG, Doug had been Group Finance Director of Umeco plc and Seton House Group Limited, having spent his early career with Williams plc in a variety of senior financial and business roles. He is currently a Non-Executive Director and Chair of the Audit Committee of HSS Hire Group plc. There is no further information to disclose pursuant to LR 9.6.13 of the Listing Rules.

Ā 

After six years, Marie-Louise Clayton, Non-Executive Director and Chair of the Audit Committee will be retiring from the Board. To provide a smooth transition, Marie-Louise will step down on 30 September 2017.

Ā 

Steve Good, Chairman of Zotefoams plc, said:

"Zotefoams has benefited greatly from Marie-Louise Clayton's contribution to the Board over the last six years and we wish her well in the future.

Ā 

We are delighted to welcome Doug Robertson to the Group. His background in international industrial markets and extensive commercial and financial experience will be of great value to the Board as the Group pursues its ambitious strategy for growth."

Ā 

- Ends -

Ā 

Enquiries:

Ā 

Zotefoams plc

+44 (0)208 664 1600

David Stirling, Group CEO

Gary McGrath, Group CFO

FTI Consulting

+44 (0)203 727 1000

Victoria Foster Mitchell / Simon Conway

Ā 

Ā 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces and sells lightweight AZOTEĀ® polyolefin and ZOTEKĀ® high-performance foams for diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FITĀ® advanced insulation for demanding industrial markets. In addition, Zotefoams owns and licenses patented MuCellĀ® microcellular foam technology, developed specifically for extrusion applications, from a base in Massachusetts, USA to customers worldwide.

Ā 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FITĀ®).

Ā 

www.zotefoams.com

Ā 

AZOTEĀ®, ZOTEKĀ®, T-FITĀ® are registered trademarks of Zotefoams plc

MuCellĀ® is a registered trademark of Trexel Inc.

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
BOAOKODKDBKBKFK
Date   Source Headline
2nd Aug 20224:35 pmRNSPrice Monitoring Extension
20th Jul 20224:42 pmRNSSecond Price Monitoring Extn
20th Jul 20224:36 pmRNSPrice Monitoring Extension
12th Jul 202212:39 pmRNSDirector/PDMR Shareholding
8th Jul 20227:00 amRNSNotice of Results
30th Jun 20224:52 pmRNSDirector/PDMR Shareholding
8th Jun 20224:40 pmRNSSecond Price Monitoring Extn
8th Jun 20224:35 pmRNSPrice Monitoring Extension
8th Jun 20228:49 amRNSDirector/PDMR Shareholding
26th May 20224:41 pmRNSSecond Price Monitoring Extn
26th May 20224:36 pmRNSPrice Monitoring Extension
25th May 20221:04 pmRNSResult of the 2022 Annual General Meeting
25th May 20227:00 amRNSTrading Update
18th May 20224:41 pmRNSSecond Price Monitoring Extn
18th May 20224:36 pmRNSPrice Monitoring Extension
12th May 20223:58 pmRNSDirector/PDMR Shareholding
11th May 20222:13 pmRNSDirector/PDMR Shareholding
25th Apr 20225:16 pmRNSDirector/PDMR Shareholding
25th Apr 20227:00 amRNS2021 Annual Report and Notice of the 2022 AGM
11th Apr 20223:49 pmRNSDirector/PDMR Shareholding
22nd Mar 20227:00 amRNSPreliminary Results
14th Mar 202212:30 pmRNSDirector/PDMR Shareholding
25th Feb 20227:00 amRNSNotice of results and investor presentation
15th Feb 20224:26 pmRNSDirector/PDMR Shareholding
27th Jan 20227:00 amRNSFull Year Trading Update
12th Jan 202211:12 amRNSDirector/PDMR Shareholding
23rd Dec 20211:56 pmRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSTrading Update
14th Dec 202111:55 amRNSDirector/PDMR Shareholding
12th Nov 202112:41 pmRNSDirector/PDMR Shareholding
10th Nov 20215:48 pmRNSHolding(s) in Company
4th Nov 20215:59 pmRNSHolding(s) in Company
4th Nov 20213:31 pmRNSDirector/PDMR Shareholding
3rd Nov 20217:00 amRNSQ3 Trading Update
15th Oct 202112:10 pmRNSDirector/PDMR Shareholding
12th Oct 202111:05 amRNSDirector/PDMR Shareholding
1st Oct 20213:31 pmRNSHolding(s) in Company
14th Sep 202110:05 amRNSDirector/PDMR Shareholding
12th Aug 20212:28 pmRNSDirector/PDMR Shareholding
10th Aug 20217:00 amRNSInterim Results
19th Jul 20219:26 amRNSNotice of Results
13th Jul 20211:59 pmRNSDirector/PDMR Shareholding
14th Jun 20213:06 pmRNSDirector/PDMR Shareholding
14th Jun 202111:35 amRNSDirector/PDMR Shareholding
10th Jun 20214:41 pmRNSDirector/PDMR Shareholding
9th Jun 20213:48 pmRNSDirector/PDMR Shareholding
2nd Jun 20213:49 pmRNSHolding(s) in Company
26th May 202112:08 pmRNSResult of AGM
26th May 20217:00 amRNSTrading Update
12th May 20213:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.